OPKO Health, Inc. (OPK)
1.18
+0.03
(+2.61%)
USD |
NASDAQ |
Feb 25, 16:00
1.17
-0.01
(-0.85%)
Pre-Market: 08:13
OPKO Health Research and Development Expense (Quarterly) : 30.08M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 569.00M |
| AtriCure, Inc. | 22.74M |
| OrthoPediatrics Corp. | 2.333M |
| Plus Therapeutics, Inc. | 2.436M |
| Nutriband, Inc. | 0.4571M |